Repositorio Dspace

Hematic Antegrade Repriming: A Reproducible Method to Decrease the Cardiopulmonary Bypass Insult

Mostrar el registro sencillo del ítem

dc.contributor.author Blanco-Morillo, Juan
dc.contributor.author Arribas-Leal, José-María
dc.contributor.author Farina, Piero
dc.contributor.author Fernández-González, Angel-Luis
dc.contributor.author Sornichero-Caballero, Ángel
dc.contributor.author Ramírez-Romero, Pablo
dc.contributor.author Chen, Tyler-N
dc.contributor.author Salmerón-Martínez, Diego
dc.contributor.author Cánovas-López, Sergio-Juan
dc.date.accessioned 2025-05-06T10:42:01Z
dc.date.available 2025-05-06T10:42:01Z
dc.date.issued 2021
dc.identifier.citation Blanco-Morillo J, Arribas-Leal JM, Farina P, Fernández-González AL, Sornichero-Caballero Á, Ramírez-Romero P, et al. Hematic Antegrade Repriming: A Reproducible Method to Decrease the Cardiopulmonary Bypass Insult. J Extra Corpor Technol. marzo de 2021;53(1):75-9.
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/18841
dc.description.abstract The current practice of cardiopulmonary bypass (CPB) requires a preoperative priming of the circuit that is frequently performed with crystalloid solutions. Crystalloid priming avoids massive embolism but is unable to eliminate all microbubbles contained in the circuit. In addition, it causes a sudden hemodilution which is correlated with transfusion requirements and an increased risk of cognitive impairment. Several repriming techniques using autologous blood, collectively termed retrograde autologous priming (RAP), have been demonstrated to reduce the hemodilutional impact of CPB. However, the current heterogeneity in the practice of RAP limits its evidence and benefits. Here, we describe hematic antegrade repriming as an easy and reliable method that could be applied with any circuit in the market to decrease transfusion requirements, emboli, and inflammatory responses, reducing costs and the impact of CPB on postoperative recovery.
dc.language.iso eng
dc.publisher EDP Sciences
dc.rights Atribución-NoComercial-SinDerivadas 4.0 España
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es *
dc.subject.mesh Blood Transfusion
dc.subject.mesh Blood Transfusion, Autologous
dc.subject.mesh Cardiopulmonary Bypass
dc.subject.mesh Crystalloid Solutions
dc.subject.mesh Hemodilution
dc.subject.mesh Humans
dc.title Hematic Antegrade Repriming: A Reproducible Method to Decrease the Cardiopulmonary Bypass Insult
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 33814610
dc.relation.publisherversion https://dx.doi.org/10.1051/ject/202153075
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.1051/ject/202153075
dc.journal.title Journal of Extra-Corporeal Technology
dc.identifier.essn 0022-1058


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-SinDerivadas 4.0 España Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 4.0 España

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta